Lymphoid Leukemia — Trials

Lymphoid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 827
Recruiting: 465
Ph III recruiting: 43
Growth YoY: −7.8%
Industry share: 18%
Top sponsor: City of Hope Medical Center
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (489)

clinicaltrialsPublishedShowing 101–104 of 104 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04499573	Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL	active not recruiting	Phase 1 / Phase 2	50	Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyOTHER	1	Feb 22, 2023	clinicaltrials
NCT04214886	CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies	active not recruiting	Phase 1	24	Loyola UniversityOTHER	1	Aug 15, 2022